Refine by
Ovarian Cancer Articles & Analysis
34 articles found
ENPP2 in Disease: Insights from Cancer, Fibrosis, and Neurobiology Pathological dysregulation of ENPP2 is associated with multiple diseases. In oncology, elevated ENPP2 expression enhances LPA-mediated signaling, driving tumor proliferation, invasion, and metastasis in breast, ovarian, and liver cancers. Experimental models show that inhibiting ...
Human ovarian epithelial cells play a crucial role in ovarian function and have become a significant focus in cancer research, specifically ovarian cancer. ...
A single missing fucose residue can enhance antibody-dependent cellular cytotoxicity by 50-fold, revolutionizing cancer immunotherapy approaches. The analytical challenge is immense. ...
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. This significant advancement represents a vital leap in the quest for more precise and effective treatments for ...
CD BioSciences has launched new services on anti-centrosome antibody development to assist cancer preclinical research. It is committed to providing full packages from antigen synthesis to antibody generation and manufacturing. ...
ESMO updated its recommendations for NGS in advanced cancers this year, urging broader use of NGS in additional cancer types and the inclusion of tumor-agnostic biomarkers. The ESMO Precision Medicine Working Group (PMWG) first published its recommendations for when to use next-generation sequencing (NGS) in routine practice for patients with metastatic ...
By combining the assets and domain expertise of both organizations, this collaboration aimed to improve ovarian cancer prognosis and treatment through accurate patient stratification and survival outcome predictions. ...
They are used in the treatment of cancer, particularly breast and ovarian cancer. Terpenes are a large class of natural compounds found in plants. ...
The two antigen-binding arms respectively bind to two antigens on the surface of cancer cells, which can effectively enhance the binding specificity and targeting of the antibody to cancer cells and reduce side effects such as off-target. ...
Further complexity arises as cancer cells also express the adenosine A1 receptor (ADORA1) and A3 receptor (ADORA3). ...
It is used to treat adult patients with metastatic triple-negative breast cancer (mTNBC) and locally advanced or metastatic urothelial cancer (UC) who have received at least 2 therapies in the past. ...
By inhibiting this enzyme, camptothecin prevents cancer cells from dividing and can induce cell death. Several derivatives of camptothecin, such as irinotecan and topotecan, have been developed and approved for the treatment of various cancers, including colorectal, lung, and ovarian cancers. ...
CADM1 and Ovarian Cancer In ovarian cancer, CADM1 downregulation has been observed in certain subtypes. ...
Introduction Genomics has revolutionized cancer research, transforming the way we diagnose, treat, and monitor cancer. ...
Enfortumab vedotin-ejfv (PADCEV®) is a first-in-class antibody-drug conjugate (ADC) that targets Nectin-4, a cell surface protein highly expressed in bladder cancer. Preclinical data suggest that the anticancer activity of Enfortumab Vedotin is attributed to its binding to cells expressing Nectin-4, followed by internalization and release of the anti-tumor agent monomethyl ...
The antibody can be released to partially target and attach to HER2 on cancer cells, and upon entering the cancer cells, release chemotherapeutic drugs to kill the cancer cells as well as nearby cells. ...
BioMark Diagnostics Inc. is a Canadian-based cancer diagnostic company with head office located in Richmond, British Columbia and operating lab in Quebec City, Quebec. ...
The Role of Mesothelin in Cancer Mesothelin is expressed in many solid tumors, most commonly in mesothelioma, epithelial ovarian and pancreatic cancers, but also in lung and uterine malignancies and in cholangiocarcinomas. Mesothelin is highest expressed in ovarian cancer and mesothelioma, and higher expression ...
Currently, ADC has played a significant role in the treatment of some malignant tumors, such as trastuzumab in the treatment of breast cancer, but its application in the treatment of prostate cancer (PCa) progress slowly. ...
Role of mesothelin in cancer and signaling Mesothelin is expressed in many solid tumors, most commonly in mesothelioma, epithelial ovarian, and pancreatic cancers, as well as in lung and uterine malignancies and bile duct cancer. Mesothelioma and ovarian cancer have the highest expression of ...